Melissa Marochi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Melissa Marochi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anna Letícia
Faculty of Medicine Federal University of the Rio Grande Rio Grande Brazil
1 shared publication - Karla Pereira Machado
Universidade Federal de Pelotas, Brasil
1 shared publication - Mirelle de Oliveira Saes
Universidade Federal do Rio Grande
1 shared publication - Rodrigo Cesar Zoppellaro Reis
Universidade Federal do Rio Grande
1 shared publication - Rosália Garcia Neves
Federal University of Rio Grande, Rio Grande, Brazil
1 shared publication - Suele Manjourany Silva Duro
Universidade Federal de Pelotas
1 shared publication
Latest Publications
- 5 September 2024
- Published by Wiley in Journal of Sleep Research
- Vol. 34 (2) , e14327
Long COVID symptoms and sleep problems: a population‐based study
Summary: To investigate the association between symptoms of long‐term effects of coronavirus disease 2019 (long COVID) and sleep problems in a sample population from southern Brazil. This cross‐sectional study used data from the SULcovid‐19 survey, developed in the municipality of Rio Grande, RS, Brazil. The outcome, long COVID, was investigated through the presence of 18 symptoms, and the exposure variable was sleep problems. Poisson regression with robust adjustment for variance was used to estimate crude and adjusted prevalence ratios for the outcome–exposure relationship. Odds ratio was calculated through multinomial regression of the relationship between the number of symptoms of long COVID and sleep problems. Analyses were adjusted for sex, age, marital status, income, body mass index, smoking status, comorbidities, and hospital admission. A total of 2919 adults and older adults were interviewed. The prevalence of long COVID was 48.3% (95% confidence interval [CI] 46.5–50.1%) and sleep problems were reported by 41.2% of the sample (95% CI 39.4–43.0%). Individuals with sleep problems were more likely to exhibit altered sensitivity (prevalence ratio [PR] 3.27; 95% CI 1.96–5.45), nasal congestion (PR 2.75; 95% CI 1.53–4.94), musculoskeletal symptoms (PR 1.75; 95% CI 1.48–2.06), respiratory issues (PR 1.58; 95% CI 1.24–2.01), and one or more symptom of long COVID (PR 1.27; 95% CI 1.15–1.39). Approximately one‐half of the population analysed had long COVID, and four of 10 reported experiencing sleep problems. In addition, the sample tended to have experienced a greater number of symptoms compared with those who reported to sleep well.
- 5 September 2024
- Published by Wiley in Journal of Sleep Research
- Vol. 34 (2) , e14327
Long COVID symptoms and sleep problems: a population‐based study
Summary: To investigate the association between symptoms of long‐term effects of coronavirus disease 2019 (long COVID) and sleep problems in a sample population from southern Brazil. This cross‐sectional study used data from the SULcovid‐19 survey, developed in the municipality of Rio Grande, RS, Brazil. The outcome, long COVID, was investigated through the presence of 18 symptoms, and the exposure variable was sleep problems. Poisson regression with robust adjustment for variance was used to estimate crude and adjusted prevalence ratios for the outcome–exposure relationship. Odds ratio was calculated through multinomial regression of the relationship between the number of symptoms of long COVID and sleep problems. Analyses were adjusted for sex, age, marital status, income, body mass index, smoking status, comorbidities, and hospital admission. A total of 2919 adults and older adults were interviewed. The prevalence of long COVID was 48.3% (95% confidence interval [CI] 46.5–50.1%) and sleep problems were reported by 41.2% of the sample (95% CI 39.4–43.0%). Individuals with sleep problems were more likely to exhibit altered sensitivity (prevalence ratio [PR] 3.27; 95% CI 1.96–5.45), nasal congestion (PR 2.75; 95% CI 1.53–4.94), musculoskeletal symptoms (PR 1.75; 95% CI 1.48–2.06), respiratory issues (PR 1.58; 95% CI 1.24–2.01), and one or more symptom of long COVID (PR 1.27; 95% CI 1.15–1.39). Approximately one‐half of the population analysed had long COVID, and four of 10 reported experiencing sleep problems. In addition, the sample tended to have experienced a greater number of symptoms compared with those who reported to sleep well.